Organigram Global (OGI) Non-Current Assets (2018 - 2025)
Organigram Global (OGI) posted quarterly Non-Current Assets of $201.5 million for Q3 2025, up 88.74% year-over-year from $106.8 million in Q3 2024, and up 88.74% quarter-over-quarter from $106.8 million in Q3 2024.
Organigram Global (OGI) Non-Current Assets (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Non-Current Assets for 8 consecutive years, with $201.5 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Non-Current Assets rose 88.74% year-over-year to $201.5 million; the TTM figure through Sep 2025 stood at $690.6 million (down 4.76% YoY), while the FY2025 annual figure was $201.5 million, up 88.74% from the prior year.
- Non-Current Assets rose to $201.5 million in Q3 2025 per OGI's latest filing, from $106.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $276.0 million in Q3 2022 and bottomed at $106.3 million in Q3 2023.
- Historically, Non-Current Assets has averaged $197.9 million across 5 years, with a median of $218.8 million in 2021.
- Annual changes were most pronounced in 2021 — Non-Current Assets fell 11.37% — and 2025, when it soared 88.74%.
- Organigram Global's Non-Current Assets stood at $236.0 million in 2021, then climbed by 16.95% to $276.0 million in 2022, then sank by 61.5% to $106.3 million in 2023, then increased by 0.45% to $106.8 million in 2024, then jumped by 88.74% to $201.5 million in 2025.
- Business Quant data shows OGI's Non-Current Assets at $201.5 million in Q3 2025, $106.8 million in Q3 2024, and $106.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.96 Bn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 201.51 Mn |
| Sep 30, 2024 | 106.76 Mn |
| Sep 30, 2023 | 106.28 Mn |
| Aug 31, 2022 | 276.04 Mn |
| Aug 31, 2021 | 236.03 Mn |
| Feb 28, 2021 | 260.51 Mn |
| Nov 30, 2020 | 265.00 Mn |
| Aug 31, 2020 | 197.15 Mn |
| May 31, 2020 | 193.82 Mn |
| Feb 29, 2020 | 293.94 Mn |
| Aug 31, 2019 | 175.67 Mn |
| May 31, 2019 | 195.52 Mn |
| Aug 31, 2018 | 75.88 Mn |